FAA Approves J&J COVID Vaccine for Safety-Sensitive Roles | Aero-News Network
Aero-News Network
RSS icon RSS feed
podcast icon MP3 podcast
Subscribe Aero-News e-mail Newsletter Subscribe

Airborne Unlimited -- Most Recent Daily Episodes

Episode Date

Airborne-Monday

Airborne-Tuesday

Airborne-Wednesday Airborne-Thursday

Airborne-Friday

Airborne On YouTube

Airborne-Unlimited-05.06.24

Airborne-NextGen-05.07.24

Airborne-Unlimited-05.08.24 Airborne-FlightTraining-05.09.24

Airborne-Unlimited-05.10.24

Sat, Dec 31, 2022

FAA Approves J&J COVID Vaccine for Safety-Sensitive Roles

Recipients Required to Wait 48 Hours Prior to Performing Duties

The FAA has followed through on a COVID-19 vaccination approval, now allowing the Johnson & Johnson (Janssen) COVID-19 vaccine for pilots, controllers, and similar roles. 

The news honors an Emergency Use Authorization from the U.S. Food and Drug Administration. The FAA has determined that the vaccine is allowable under the conditions of their FAA-issued airman medical certification. FAA and contract air traffic controllers, who are subject to FAA medical clearance, may also receive the vaccine. That shot comes with a caveat just like it did last year, requiring a short pause before resuming work duties.

"To maintain the highest level of safety in the National Airspace System," the announcement read. "The FAA will require the affected recipients of this single-dose vaccine to wait 48 hours before conducting safety-sensitive aviation duties, such as flying or controlling air traffic. The waiting period, which accounts for potential side effects, applies to those holding an Airman Medical Certificate issued under 14 CFR Part 67 or a Medical Clearance issued under FAA Order 3930.3C."

The FAA says that their staff of medical professionals will "continuously monitor the initial distribution of the Johnson & Johnson COVID-19 vaccine and will adjust the recommendations as needed," leaving enough slack on the table in case of changing conditions. The speed of fresh COVID strains and vaccine formulations may have kept the administration on their toes after 2021, prompting them to remain ready for any changes in the pipeline. They say that they will "evaluate additional vaccines as they receive FDA emergency use authorization and will advise pilots and air traffic controllers of any required waiting periods".

For now, the J&J requirements could be seen to be a fair template of what to expect for other brands, as it falls perfectly in line with similar 48-hour waiting periods for its competing Moderna and Pfizer products. The FAA notes that similar waiting periods apply to other vaccines too, like tuberculosis and typhoid.

FMI: www.faa.gov

Advertisement

More News

Airborne-Flight Training 05.09.24: ERAU at AIAA, LIFT Diamond Buy, Epic A&P

Also: Vertical Flight Society, NBAA Maintenance Conference, GA Honored, AMT Scholarship For the first time, students from Embry-Riddle’s Daytona Beach, Florida, campus took t>[...]

ANN's Daily Aero-Term (05.07.24): Hazardous Weather Information

Hazardous Weather Information Summary of significant meteorological information (SIGMET/WS), convective significant meteorological information (convective SIGMET/WST), urgent pilot>[...]

Aero-News: Quote of the Day (05.07.24)

"The need for innovation at speed and scale is greater than ever. The X-62A VISTA is a crucial platform in our efforts to develop, test and integrate AI, as well as to establish AI>[...]

NTSB Final Report: Cessna 150

(FAA) Inspector Observed That Both Fuel Tanks Were Intact And That Only A Minimal Amount Of Fuel Remained In Each Analysis: According to the pilot, approximately 8 miles from the d>[...]

Aero-News: Quote of the Day (05.08.24)

“Pyka’s Pelican Cargo is unlike any other UAS solution on the market for contested logistics. We assessed a number of leading capabilities and concluded that the Pelica>[...]

blog comments powered by Disqus



Advertisement

Advertisement

Podcasts

Advertisement

© 2007 - 2024 Web Development & Design by Pauli Systems, LC